http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2468371-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 |
| filingDate | 1980-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c |
| publicationDate | 1981-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2468371-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL NUTRITION |
| abstract | Pharmaceutical compositions suitable for parenteral administration and useful for feeding patients who cannot enter enterally, characterized by comprising: a nutritionally effective amount of glucose; an amount of L-carnitine or acyl-L-carnitine, in which the acyl radical contains from 2 to 6 carbon atoms, or of a pharmaceutically acceptable salt, ester or amide, which is sufficient to enhance the use glucose, while avoiding excessive secretion of insulin by patients; and a pharmaceutically acceptable liquid excipient. |
| priorityDate | 1979-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.